ARTV
NASDAQ · Biotechnology
Artiva Biotherapeutics Inc
$4.03
+0.16 (+4.13%)
Open$4.05
Previous Close$3.87
Day High$4.13
Day Low$3.90
52W High$8.16
52W Low$6.24
Volume—
Avg Volume259.3K
Market Cap98.92M
P/E Ratio42.25
EPS$0.18
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+102.0% upside
Current
$4.03
$4.03
Target
$8.14
$8.14
$7.28
$8.14 avg
$10.62
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.19M | 14.43M | 14.50M |
| Net Income | -2,971,681 | -2,421,627 | -2,767,986 |
| Profit Margin | -19.6% | -16.8% | -19.1% |
| EBITDA | -2,996,612 | -2,990,686 | -3,421,626 |
| Free Cash Flow | -2,370,454 | -1,604,262 | -1,971,320 |
| Rev Growth | -5.2% | +14.0% | +5.2% |
| Debt/Equity | 0.33 | 0.31 | 0.27 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |